We are offering the COVID-19 vaccine to eligible patients based on state and federal guidelines, and as supplies allow. Please do not call us for a vaccine appointment. We are notifying patients individually when they can schedule. Create a MyChart account so we can notify you. Learn more about the COVID-19 vaccine.

If you need help accessing our website, call 855-698-9991
Skip to main content
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Alexander McMeeking, MD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Infectious Diseases, Internal Medicine
  • Language: English
  • Phone: 212-929-2629
View Locations

Conditions and Treatments

Conditions
  • Lyme disease
  • acquired immunodeficiency syndrome
  • viral hepatitis
  • hepatitis C
  • human immunodeficiency virus
Treatments
  • primary care
  • immunization
  • travel vaccination

Positions
Board Certifications
  • American Board of Internal Medicine (Infectious Disease), 1988
  • American Board of Internal Medicine - Internal Medicine, 1985
Education and Training
  • Fellowship, NYU Medical Center, Infectious Diseases, 1987
  • Residency, St. Luke's Roosevelt Hospital, Internal Medicine, 1985
  • MD from UMDNJ, 1982

Is this your profile?

Edit profile

Locations and Appointments

110 East 40th Street, Suite 507
New York, NY 10016

Interests

new therapies for HIV

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

  • A Phase III Randomized Double-blind Placebo-controlled Multicenter Study in Adults to Determine the Safety Efficacy and Immunogenicity of AZD1222 a Non-replicating ChAdOx1 Vector Vaccine for the Prevention of COVID-19

    Learn More
  • A Phase 1/2 Placebo-Controlled Randomized Observer-Blind Dose-Finding Study to Describe the Safety Tolerability Immunogenicity and Potential Efficacy of SARS CoV 2 RNA Vaccine Candidates Against COVID 19 in Healthy Adults

    Learn More
  • Specimen Collection for Infectious Diseases with Public Health Importance

    Learn More
View All Research Studies (4)

Read All Publications (20)